...
首页> 外文期刊>Developmental Immunology: Journal of Immunology Research >Research of the Methylation Status of miR-124a Gene Promoter among Rheumatoid Arthritis Patients
【24h】

Research of the Methylation Status of miR-124a Gene Promoter among Rheumatoid Arthritis Patients

机译:类风湿关节炎患者miR-124a基因启动子甲基化状态的研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective. To analyze the methylation status of miR-124a loci in synovial tissues of rheumatoid arthritis (RA) patients using methylation-specific polymerase chain reaction (MSP).Materials and Methods. DNA obtained from the frozen tissue of 7 RA samples, 6 osteoarthritis (OA) samples, and 3 healthy controls were undergoing bisulfite conversion and then analyzed for miR-124a promoter methylation using MSP assay.Results. miR-124-a1 and miR-124-a2 promoter methylation were both seen in 71.4% of RA samples compared to 16.7% of OA samples. miR-124-a3 promoter methylation was seen in 57.1% of RA samples and 0% of OA samples. All the three loci were unmethylated in 3 healthy controls.Conclusion. The methylation status of miR-124a seen in this study concurs with that reported in tumor cells, indicating epigenetic dysregulation constituents, a mechanism in the development of rheumatoid arthritis.
机译:目的。使用甲基化特异性聚合酶链反应(MSP)分析类风湿关节炎(RA)患者滑膜组织中miR-124a基因座的甲基化状态。材料和方法。从7个RA样本,6个骨关节炎(OA)样本和3个健康对照的冰冻组织中获得的DNA进行亚硫酸氢盐转化,然后使用MSP分析法分析miR-124a启动子甲基化。 miR-124-a1和miR-124-a2启动子甲基化在71.4%的RA样品中均可见,而OA样品的16.7%。在57.1%的RA样品和0%的OA样品中发现了miR-124-a3启动子甲基化。在3个健康对照中,所有三个基因座均未甲基化。在这项研究中看到的miR-124a的甲基化状态与肿瘤细胞中报道的状态一致,表明表观遗传失调成分是类风湿关节炎发展的一种机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号